Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors.
diversity
equity
inclusion
infectious diseases fellowship
medical education
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
13
02
2023
accepted:
17
05
2023
medline:
3
7
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
epublish
Résumé
The Infectious Diseases Society of America (IDSA) has set clear priorities in recent years to promote inclusion, diversity, access, and equity (IDA&E) in infectious disease (ID) clinical practice, medical education, and research. The IDSA IDA&E Task Force was launched in 2018 to ensure implementation of these principles. The IDSA Training Program Directors Committee met in 2021 and discussed IDA&E best practices as they pertain to the education of ID fellows. Committee members sought to develop specific goals and strategies related to recruitment, clinical training, didactics, and faculty development. This article represents a presentation of ideas brought forth at the meeting in those spheres and is meant to serve as a reference document for ID training program directors seeking guidance in this area.
Identifiants
pubmed: 37397270
doi: 10.1093/ofid/ofad289
pii: ofad289
pmc: PMC10313091
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofad289Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. All authors: No reported conflicts.
Références
J Infect Dis. 2020 Sep 14;222(Suppl 6):S523-S527
pubmed: 32926738
J Grad Med Educ. 2021 Jun;13(3):335-344
pubmed: 34178258
Am J Med. 2022 Dec;135(12):1509-1516.e1
pubmed: 35981650
Acad Med. 1995 Dec;70(12):1142-4
pubmed: 7495461
OTO Open. 2022 Jul 30;6(3):2473974X221113847
pubmed: 35923218
JAMA Intern Med. 2019 Dec 1;179(12):1678-1685
pubmed: 31657839
Lancet. 2019 Feb 9;393(10171):579-586
pubmed: 30739693
Health Sci Rep. 2020 Apr 20;3(2):e2161
pubmed: 32318628
J Infect Dis. 2019 Aug 20;220(220 Suppl 2):S62-S73
pubmed: 31430386